Assessment of Medication Adherence in Rheumatoid Arthritis Patients
|
|
|
- Juniper Welch
- 10 years ago
- Views:
Transcription
1 J.J. Appl. Sci. Vol. 10, No. 2 (2008) Assessment of Medication Adherence in Rheumatoid Arthritis Patients Kholoud Z. Qoul, Ikbal N. Thuheerat & Imad Al-Dogham Royal Medical Services, Amman, Jordan Received: 18/10/2007 Accepted: 5/6/2008 Qoul, Kholoud Z., Ikbal N. Thuheerat & Imad Al-Dogham (2008) Assessment of Medication Adherence in Rheumatoid Arthritis Patients. J.J. Appl. Sci: Natural Sciences Series 10 (2): Abstract: The objective of this study is to assess medication adherence in rheumatoid arthritis patients, focusing on the reasons and barriers. The study was conducted at King Hussein Medical Center (Royal Rehabilitation Center) between February and June A specially designed questionnaire was delivered through direct interview provided by researchers to a total of 110 rheumatoid patients. These 110 patients met the following inclusion criteria: adult rheumatoid patients, taking at least one of the disease modifying anti-rheumatic drugs plus non-steroidal anti-inflammatory drugs, and their disease duration not less than one year. The study was approved by the ethical committee of the Royal Medical Services. Among the 110 patients included in the study, eighty-two (75.0%) were females and twenty-eight (25.0%) were males. Patients aged between years with a mean of 45± (8.5). The median duration of the patients disease was seven years. Regarding the number of medications, 72.0% of the patients were on three or more medications, while 28.0% were taking less than three medications. Only 72 patients (65.0%) adhered to their medications whereas 38 patients (35.0%) did not adhere to their medications. Among the nonadherent patients, (72.0%) of them stopped taking their medications as soon as they improved, while (3.0%) of them stopped taking their medications once their condition got worse. For prescription refilling, the study showed that (49.0%) of the "non-adherent" patients refilled their prescription on time, compared to (51.0%) who were late on refilling their prescription. The study revealed that the top factors and reasons of non-adherence include side effects of medications, lack of belief in the benefit of treatment, and switching to different brand name, and medication load. (76.3%) of non-adherent patients indicated that their non-adherence was due to side effects of medications, (73.7%) was due to lack of belief in the benefit of treatment, (71.0%) was due to switching to different brand names, and (63.2%) was due to medication load. Key words: adherence, rheumatoid arthritis, medication, non-adherence. (2008). :(2) 10 : :. ( ) : (%75) %72. 7 %28. (%65) 72 (%35) 38. %72. %3 %49 %51. : % 73.7 % 76.3 %63.2 * Principal author's address: [email protected] %
2 Kholoud Qoul, Ikbal Thuheerat & Imad Al-dogham Introduction There are several definitions for adherence (or compliance) to a medication regimen. One definition states that it is "the extent to which patients take medications as prescribed by their health care providers".[1] Yet, another definition states that it is "the extent to which a person's medication taking behavior coincides with medical advice".[2] Adherence is advocated by health care providers because compliance suggests that the patient is passively following the doctor's order. Additionally, it suggests that the treatment plan is not based on a therapeutic alliance or contract established between the patient and the physician.[1] Several studies suggest that the ability of health workers to recognize nonadherence is poor, and that interventions to improve adherence have had mixed results.[1] Key elements to determine an individual's adherence to treatment include: threat of illness, positive outcome expectancy (perceived severity and susceptibility), barriers for using the treatment (e.g. expected disadvantage from treatment), and intent (intention to adhere to the treatment regimen).[3] Adherence to therapy is an individual patient behavior that is difficult to objectively measure, monitor, and improve. It is widely believed that nonadherence is a serious problem, with particularly high estimates of non-adherence for older adults and for individuals with chronic disease as rheumatoid arthritis (RA).[4] Rheumatoid arthritis (RA) is one of the most serious diseases with rates of morbidity and mortality equal to those caused by malignancy. They also exact a major personal and financial toll on the patient and their families through pain, disability, reduced self-esteem, and loss of income.[5] The aim of this study is to identify the underlying reasons for rheumatoid arthritis patients for being non-adherent to their medication. Such identification helps the physician to isolate patients who need intervention to improve adherence. Nonadherence is considered as a marker of a problem in the process of prescribing and the experience of using medication. Non-adherence may result in unnecessary health costs, investigations, changes in treatment, morbidity, and mortality.[4] The findings of the study could be used to improve the quality of patient care. A critical element in successful clinical treatment of a disorder is that patients take the medication that is prescribed to them.[6] Methods The study was conducted at King Hussein Medical Center (Royal Rehabilitation Center) between February and June A specially designed questionnaire (Appendix 1) was delivered through direct interview provided by researchers to a total of 110 rheumatoid patients. These 110 patients met the following inclusion criteria: adult rheumatoid patients, taking at least one of the disease modifying anti-rheumatic drugs (DMARDs) with non-steroidal anti-inflammatory drugs (NSAIDs). The interview questionnaire is divided into two parts. The first part collects general information about the patients (i.e., age, gender, educational level, etc.). The second part collects information regarding adherence practice by patients in addition to the responses of "non-adherent" patients to the reasons that cause their non-adherence. 80
3 J.J. Appl. Sci. Vol. 10, No. 2 (2008) Patients who answered "sometimes" when asked about their adherence were considered "non-adherent" patients by the researchers. The data was analyzed by utilizing descriptive statistics in terms of number and percentage of patients. The study was approved by the ethical committee of the Royal Medical Services. Results The total number of patients studied is 110 participants aged between years (45±8.5). Among the participants, 82 (75.0%) are females, while 28 (25.0%) are males. The median duration of the patients disease is seven years. One quarter of the patients have the disease for less than 4 years, half of the patients have the disease for 4 to 10 years, and one quarter of the patients have the disease for more than 10 years. Table (1) shows that about 20% of the patients are illiterate, 30% elementary school education, 32.0% have a high school diploma, 10% have a community college diploma, and 8.0% have a university degree. Table 1: Patient characteristics Characteristics % Male Female Educational level: Illiterate Elementary education High school diploma Community college diploma University degree Number of medication taken by the sample patients: 3 <3 Adherence Non-adherence Missing their doses (non-adherent): Rarely Sometimes Refilling their medication prescription (non-adherent): Late On time Number of medication taken by the non-adherent patients: 3 <
4 Kholoud Qoul, Ikbal Thuheerat & Imad Al-dogham Seventy-two percent of the patients were taking three or more medications, while 28.0% were taking less than three medications. The study shows that 72 patients 65.0% always adhere to their medications, 38 patients 35.0% do not adhere to their medications. Among the non-adherent patients, 72.0% stop taking their medications once they get improved, compared to 3.0% who may stop taking their medications once their condition get worse. Sixty-four percent of the non-adherent patients sometimes miss their medications, while 36.0% rarely miss their medication. For prescription refilling, the study reveals that 49.0% of the non-adherent" patients refill their prescription on time, while 51.0% were late on their prescription refilling. Table 2 shows the main reasons of non-adherence as indicated by non-adherent patients. 76.3% of the non-adherent patients indicate that one of the main reasons for non-adherence is the side effect of medications. Yet, another main reason indicated by 73.7% of the non-adherent patients is patients lack of belief in the benefit of treatment. 71.0% of the non-adherent patients indicated that switching to different brand names is a main reason for non-adherence. 63.2% of the nonadherent patients indicated that medication load 'polypharmacy' is a main cause for non-adherence. This is supported by the fact that two-thirds of the "nonadherent" patients take three or more medications (Figure 1). Table 2: Reasons for non-adherence to medication Reason n* Percentage** (%) 1. Side effect of medication Patient lack of belief in the benefit of treatment Switching to different brand names Medication load (polypharmacy) Cost of medication Busy life style or forgotten Inability of patient to access pharmacy Inadequate follow up or discharge planning Patient lack of insight into the illness Poor provider-patient relationship *n: number of non-adherent patients who provided answers for their non-adherence ** Percentage = (n/38) X 100%, where 38 is the number of non-adherent patients 82
5 J.J. Appl. Sci. Vol. 10, No. 2 (2008) 33% 67% <3 medication 3 medication Figure 1. Number of medications taken by non-adherent patients The study also reveals that other main reasons of non-adherence as indicated by non-adherent patients include: inadequate follow up or discharge planning, cost of medication, busy life style or forgotten, and inability to access pharmacy (as indicated by 52.6%), patients lack of insight of illness (as indicated by 21.0%), and poor provider-patient relationship (as indicated by 15.8%). Discussion This study shows that about two-thirds of participants adhere to their medications, compared to one-third who do not adhere to their medications. This result is consistent with the results of other studies, which show that the percentage of nonadherence ranges between 30.0% and 50.0% for patients on chronic medications.[7,8,9] Additionally, recent reports quote a range of drug adherence levels between 16.0% and 84.0%.[5,10,11] This study shows that 72.0% of non-adherent patients stop taking their medication once they get improved compared to 3.0% who stop their medication once their condition get worse. This result is almost as twice higher as another study that reports that 36.0% of studied patients' adhere to their medication frequency and dosage by either increasing or decreasing it.[12] Rate of refilling prescriptions is considered an accurate measure of overall adherence in closed pharmacy system (i.e., department of veterans' affairs heath care system) (1). Since this study is also conducted in a closed pharmacy system (Royal Rehabilitation Center), the argument of considering the rate of refilling prescriptions an accurate measure of overall adherence is valid for this study. The results of the study show that patients are almost evenly divided between those who refill their prescription on time and those who are late in refilling their prescription. Investigating medication beliefs is especially important in rheumatoid arthritis (RA) as it is a chronic disease. Patients are advised to take potentially toxic drugs, including non-steroidal anti-inflammatory drugs (NSAIDs) and disease modifying anti-rheumatic drugs (DMARDs).[6] A related study indicates that people with strong beliefs in the necessity of taking medication to maintain their health are found to be more adherent to treatment. On the other hand, patients with higher levels of concern about medication, commonly about the dangers of dependence and long-term side-effect, are more likely to be non-adherent.[13] It is found that 74.3% of rheumatoid arthritis patients have a positive belief in the necessity of their medication for maintaining health, and nearly 80.0% are concerned about potential long-term adverse effects of their medication.[6] This is consistent with the results of this study; 73.7% of non-adherent patients indicate 83
6 Kholoud Qoul, Ikbal Thuheerat & Imad Al-dogham that their lack of belief in the benefit is a reason of non-adherence to medication. Additionally, 76.3% of non-adherent patients indicated that the side effects of medication are one of the reasons for not adhering to their medications. Other studies indicated that health care systems and clinician barriers include insufficient access to physicians, lack of trust between clinician and patient, and in some cases, physician's negative attitude and inadequate knowledge about the disease and value of guideline-recommended care.[1,14] In contrast, this study shows that only 15.8% of the non-adherent patients indicated a poor providerpatient relationship for not adhering to their medications. Other studies showed that half of the patients forget to take their medication occasionally.[12] This study shows similar results with 52.6% of the non-adherent patients indicate that their busy life style and forgetfulness is a reason for not adhering to their medications. Other studies argue that forgetfulness in some cases represents the non-explicit denial of a disease and its social consequences.[15] In this study two-thirds of the non-adherent patients take equal to or more than three medications, while the remaining one-third takes less than three medications. Almost fifty three percent (52.6%) of the "non-adherent" patients indicate that the cost of medication is a reason for not adhering to their medications. This result is consistent with another study that indicates that the patients reported, financial problems, fear of side effects, difficulty navigating the public health system and perceived treatment as important barriers to adherence.[16] Additionally, another study named barriers to target for optimal adherence as: adverse effects, polypharmacy, frequency of doses (more than once daily), and high cost.[3] On other hand, Anita et al didn't find any correlation between concern about side effects and patients perception of the effectiveness of medication that translated into poor medication adherence.[12] Limitations of this study include the small sample size of patients and that the data are self-reported by patients. As a result, the analysis may be susceptible to misrepresentation and tend to result in overestimating the adherence. The humble sample size limits generalizing the findings of the study on all rheumatoid patients. Further investigation is required using larger sample size. Conclusion and Recommendation The percentage of medication adherence in rheumatoid arthritis patients is 65.0%. The most common reasons for non-adherence are side effects of medications, patients lack of belief in the benefit of treatment, and switching to different brand names. However, the least common reason is poor provider-patient relationship. The findings of the present study could be used to contribute in improving the quality of patient care. As such, more focus should be directed on reassuring patients about the safety of treatment. In particular, more emphasis should be directed to reduce patients' fears of long-term effects for taking medications, and to convince patients of the benefits of treatment. Direct counseling of patients by pharmacists may become promising because of pharmacists' specialized training and knowledge of medications and availability to patients. Methods that may be used to improve adherence include: patient education, improved dosing schedules, increase clinic opening hours, and improve communication between physicians, pharmacists, and patients. 84
7 J.J. Appl. Sci. Vol. 10, No. 2 (2008) References [1] Osterberg, L. & Blaschke, T. (2005) Adherence to medication. N Engl J Med 353, [2] Brus, H. L. M., M. A. F. J. Van De Laar., E. Taal., J. J. Rasker & O. Wiegman (1998) Effect of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis, Annals of the Rheumatic Diseases 57, [3] Simpson, R. J. (2006) Challenges for Improving Medication Adherence. JAMA 296 (21), [4] Park, D. C., Hertzog, C., Leventhal, H., Morrell, R. W., Leventhal, E., Birchmore, D., Martin, M., & Bennett, J. (1999) Medication Adherence in Rheumatoid Arthritis Patients Older is Wiser. JAGS 47 (2), [5] Hill, J., Bird, H., & Johnson, S. (2001) Effect of Patient education on adherence to drug treatment for rheumatoid arthritis: a randomized controlled trial. Annals of the Rheumatic Diseases 60, [6] Neame, R., & Hammond, A. (2005) Belief about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology 44, [7] Meichenbaum, D., & Turk, D. C. (1987) Facilitating treatment adherence: a practitioner's handbook. New York: Plenum Press. [8] Sackett, D. L. & Snow, J. C. (1979) The magnitude of compliance and noncompliance care. Baltimore, London: The John Hopkins University Press; [9] Barber, N., Parsons, J., Clifford, S., Darracott, R., and Horne, R. (2004) Patients' problems with new medication for chronic conditions. Qual saf Health Care 13, [10] Belcon, M. C., Haynes R. B., and Tugwell, P. (1984) A critical review of compliance studies in rheumatoid arthritis. Arthritis Rheum 27, [11] Bradly, L. A. (1989) Adherence with treatment regimens among adult rheumatoid arthritis patients: current status and future directions. Arthritis Care Res 2, S [12] Lim Anita, Y. N., Ellis, C., Brooksby, A., & Gaffney, K. (2007) Patient satisfaction with Rheumatology Practitioner Clinics: Can We Achieve Concordance by meeting Patients' Information Needs and Encouraging Participatory Decision Making? Ann Acad Med Singapore 36, [13] Horne, R. & Weinman, J. (1999) Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47, [14] Petrilla, A. A., Benner, J. S., Battleman, D. S., Tierce, J. C. & Hazard, E. H. (2005) Evidence-based interventions to improve patient compliance with antihypertensive and lipid-lowering medication, Int J Clin Pract 59, [15] Christensen, A. J. (2004) Patient Adherence to Medical Treatment Regimens Bridging the Gap between Behavioral Science and Biomedicine. Yale University Press, USA. [16] Chambers, S. A., Rahman, A., & Isenberg, D. A. (2007) Treatment adherence and clinical outcome in systemic lupus erythematosus. Rheumatology 46,
8 Kholoud Qoul, Ikbal Thuheerat & Imad Al-dogham Name: Age: Occupation: Income (JD): Diagnosis: RA Appendix Patient-Medication Adherence Questionnaire Patient ID: Sex: Education Level: Disability: Cognitive deficits: Other medical illness: HTN DM Others No. of medications: < 3 > 3 Part I No. Question Always Sometimes Rarely 1. Do you adhere to your medications? Do you stop taking your medicine once you improve? Do you stop taking your medicines once you get worse? 4. Do you miss your clinic appointments? 5. How often do you miss taking a dose of medicine? 6. What is your rate of prescription refilling: On time Late ---- No. Part II Choose one reason or more for non-adherence to your medication? 1. Side effect of medication. 2. Inadequate follow up or discharge planning. 3. Patients lack of belief in the benefit of treatment. 4. Patient lack of insight into the illness. 5. Poor provider-patient relationship. 6. Cost of medication. 7. Busy life style or forgotten. 8. Medication load (polypharmacy). 9. Inability of patient to access pharmacy. 10. Switching to different brand names. 11. Non-availability of medication. 12. Other reasons 13. If you choose option (12) specify the reason(s). 86
Disease Therapy Management (DTM) Enhances Rheumatoid Arthritis Treatment
A WHITE PAPER BY Disease Therapy Management (DTM) Enhances Rheumatoid Arthritis Treatment Increased adherence rates deliver improved outcomes for patients FALL 2010 The Benefits of DTM for Rheumatoid Arthritis
Overview Medication Adherence Where Are We Today?
Overview Medication Adherence Where Are We Today? This section covers the following topics: Adherence concepts and terminology Statistics related to adherence Consequences of medication nonadherence Factors
Pfizer Medical Education Group Request for Proposals (RFP) Rheumatoid Arthritis Adherence to Medications for RA
Pfizer Medical Education Group Request for Proposals (RFP) Rheumatoid Arthritis Adherence to Medications for RA I. Background The Pfizer Medical Education Group (MEG) is the unit within Pfizer that provides
An Introduction to Medication Adherence
An Introduction to Medication Adherence Medication Adherence Project (MAP) A project of the Cardiovascular Prevention & Control Program and the Fund for Public Health in New York Drugs don t work in patients
How Can We Get the Best Medication History?
How Can We Get the Best Medication History? Stephen Shalansky, Pharm.D., FCSHP Pharmacy Department, St. Paul s Hospital Faculty of Pharmaceutical Sciences, UBC How Are We Doing Now? Completeness of Medication
Pain Management Regulations Affect More Than Pain Management Specialists January 2012. Of counsel to
Pain Management Regulations Affect More Than Pain Management Specialists January 2012 LINDA A. KEEN MSN, JD, LHCRM LAW OFFICE OF LINDA A. KEEN P.A. TALLAHASSEE, FL Of counsel to Pain Management Regulations
Shared care protocol for the management of patients with Rheumatoid Arthritis treated with disease modifying antirheumatic drugs (DMARDs)
Tameside Hospital NHS Foundation Trust and NHS Tameside and Glossop Shared care protocol for the management of patients with Rheumatoid Arthritis treated with disease modifying antirheumatic drugs (DMARDs)
TAKING CARE OF YOUR RHEUMATOID ARTHRITIS
TAKING CARE OF YOUR RHEUMATOID ARTHRITIS RHEUMATOID ARTHRITIS (RA) FAST FACTS What is Rheumatoid Arthritis? Rheumatoid arthritis (RA) is a chronic disease that can affect your ability to function and be
White Paper. Medicare Part D Improves the Economic Well-Being of Low Income Seniors
White Paper Medicare Part D Improves the Economic Well-Being of Low Income Seniors Kathleen Foley, PhD Barbara H. Johnson, MA February 2012 Table of Contents Executive Summary....................... 1
BACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes
BACKGROUND More than 25% of people with diabetes take insulin ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes Insulin identified as the most effective
GUIDE TO PATIENT COUNSELLING
Guide To Patient Counselling page - 1 - GUIDE TO PATIENT COUNSELLING Communication is the transfer of information meaningful to those involved. It is the process in which messages are generated and sent
Elderly males, especially white males, are the people at highest risk for suicide in America.
Statement of Ira R. Katz, MD, PhD Professor of Psychiatry Director, Section of Geriatric Psychiatry University of Pennsylvania Director, Mental Illness Research Education and Clinical Center Philadelphia
Keeping patients safe when they transfer between care providers getting the medicines right
PART 1 Keeping patients safe when they transfer between care providers getting the medicines right Good practice guidance for healthcare professions July 2011 Endorsed by: Foreword Taking a medicine is
Diabetes and Blood Pressure PIP Care Coordinator Toolkit. Provided by: - 1 -
Diabetes and Blood Pressure PIP Care Coordinator Toolkit Provided by: - 1 - Project Summary MSHO/MSC+/SNBC Community & Institutionalized Blood Pressure Control for Members with Diabetes 2010 Performance
Medication error is the most common
Medication Reconciliation Transfer of medication information across settings keeping it free from error. By Jane H. Barnsteiner, PhD, RN, FAAN Medication error is the most common type of error affecting
MANAGEMENT OF CHRONIC NON MALIGNANT PAIN
MANAGEMENT OF CHRONIC NON MALIGNANT PAIN Introduction The Manitoba Prescribing Practices Program (MPPP) recognizes the important role served by physicians in relieving pain and suffering and acknowledges
DOCTOR DISCUSSION GUIDE FOR RHEUMATOID ARTHRITIS
DOCTOR DISCUSSION GUIDE FOR RHEUMATOID ARTHRITIS Talking your Doctor About Rheumatoid Arthritis Preparing for your Doctor s Appointment Early and aggressive treatment can help you forestall the joint damage
Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998
Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Section I: Preamble The New Hampshire Medical Society believes that principles
Current Rheumatoid Arthritis Treatment Options: Update for Managed Care and Specialty Pharmacists
Current Rheumatoid Arthritis Treatment Options: Update for Managed Care and Specialty Pharmacists 1. Which of the following matches of biologic targets that contribute to rheumatoid arthritis (RA) and
Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy
Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Judith Long, MD,RWJCS Perelman School of Medicine Philadelphia Veteran Affairs Medical Center Background Objective Overview Methods
c. determine the factors that will facilitate/limit physician utilization of pharmacists for medication management services.
Consumer, Physician, and Payer Perspectives on Primary Care Medication Management Services with a Shared Resource Pharmacists Network Marie Smith, PharmD and Michlle Breland, PhD University of Connecticut,
Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study
Improving Outcomes in Patients Who are Prescribed Alprazolam with Concurrent Use of Opioids Pik-Sai Yung, M.D. Staff Psychiatrist Center for Counseling at Walton Background and Rationale Alprazolam is
Medication Utilization. Understanding Potential Medication Problems of the Elderly
Medication Utilization Understanding Potential Medication Problems of the Elderly NICE - National Initiative for the Care of the Elderly WHAT ARE MEDICATION UTILIZATION PROBLEMS AMONG THE ELDERLY? A useful
Over-prescribing Excessive doses/duration of medicines Lacking indication. Mis-prescribing Unfavourable choice of medicine, dose, or duration
Inappropriate prescribing: STOPP-START criteria Clara Drenth-van Maanen, MD Clinical pharmacologist Risks outweighing benefits Inappropriate prescribing Over-prescribing Excessive doses/duration of medicines
Oral Oncology Treatment Regimens and the Role of Medication Therapy Management on Patient Adherence and Compliance
Oral Oncology Treatment Regimens and the Role of Medication Therapy Management on Patient Adherence and Compliance Oral Cancer Care Therapies: The Opportunity and The Challenge Chemotherapy used to treat
Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain
Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Division of Workers Compensation 04.01.2015 Background Opioids
http://nurse practitioners and physician assistants.advanceweb.com/features/articles/alcohol Abuse.aspx
http://nurse practitioners and physician assistants.advanceweb.com/features/articles/alcohol Abuse.aspx Alcohol Abuse By Neva K.Gulsby, PA-C, and Bonnie A. Dadig, EdD, PA-C Posted on: April 18, 2013 Excessive
10/31/2014. Medication Adherence: Development of an EMR tool to monitor oral medication compliance. Conflict of Interest Disclosures.
Medication Adherence: Development of an EMR tool to monitor oral medication compliance Donna Williams, RN PHN Carol Bell, NP MSN Andrea Linder, RN MS CCRC Clinical Research Nurses Stanford University SOM
Specialty Drug Care: Case management services in Quebec
Specialty Drug Care: Case management services in Quebec QUEBEC SUPPORTING HEALTHIER OUTCOMES Your health benefit plan is designed to provide you and your family with financial protection for a variety
Standards of Practice for Primary Health Care Nurse Practitioners
Standards of Practice for Primary Health Care Nurse Practitioners June 2010 (1/14) MANDATE The Nurses Association of New Brunswick is a professional organization that exists to protect the public and to
Impact of Clinical Education as Part of a Multichannel Sales Strategy
Impact of Clinical Education as Part of a Multichannel Sales Strategy June 13, 2012 Copyright 2012 Quintiles Topics Impact of Clinical Education as part of a Multichannel Sales Strategy -Introduction to
Opioid Contracts: A Tool for Providing Relief and Preventing Abuse?
Opioid Contracts: A Tool for Providing Relief and Preventing Abuse? Jane Jurcic McMaster Family Practice and Hamilton Family Health Team Hamilton, Ontario Opioid Prescribing in Chronic Pain Legitimate
Accenture Consumer Survey on Patient Engagement
Accenture Consumer Survey on Patient Engagement Research Recap: United States September 2013 Executive Highlights: Overview Accenture conducted an online survey of 9,015 adults, 18+ across nine countries:
Improving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge
Improving drug prescription in elderly diabetic patients FRANCESC FORMIGA Hospital Universitari de Bellvitge High prevalence, but also increases the incidence. The older the patients, the higher the percentages
Breakfast symposium: From hospital to home - the focus on the patient
Breakfast symposium: From hospital to home - the focus on the patient Nadya Hamedi DARZI Fellow UCLPartners and Barts Health NHS Trust in collaboration with North Central London Local Pharmaceutical Committee
MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES `I. Requirements for Prior Authorization of Cytokine and CAM Antagonists
MEDICAL ASSISTANCE HBOOK `I. Requirements for Prior Authorization of Cytokine and CAM Antagonists A. Prescriptions That Require Prior Authorization All prescriptions for Cytokine and CAM Antagonists must
NYC Health Department Surveillance Study: Barriers to Hep C Treatment Among NYC Residents
NYC Health Department Surveillance Study: Barriers to Hep C Treatment Among NYC Residents Andrea V. King, MPH New York City Department of Health and Mental Hygiene GOALS OF OUR STUDY To describe clinical
Maryland Cancer Plan Pain Management Committee
Maryland Cancer Plan Pain Management Committee IDEAL MODEL FOR CANCER CONTROL PROBLEM or ISSUE Lack of provider awareness regarding appropriate pain assessment and management and relevant policy Definition:
Treatment of Chronic Pain: Our Approach
Treatment of Chronic Pain: Our Approach Today s webinar was coordinated by the National Association of Community Health Centers, a partner with the SAMHSA-HRSA Center for Integrated Health Solutions SAMHSA
Early Rehabilitation of Rheumatoid Arthritis (RA)
Early Rehabilitation of Rheumatoid Arthritis (RA) Results and Hands-On Experiences with the Implementation of a Randomized Controlled Trial in Health Services Research Susanne Schlademann University of
Chapter 4 Health Care Management Unit 1: Care Management
Chapter 4 Health Care Unit 1: Care In This Unit Topic See Page Unit 1: Care Care 2 6 Emergency 7 4.1 Care Healthcare Healthcare (HMS), Highmark Blue Shield s medical management division, is responsible
Program Approved by AoA, NCOA. Website: www.homemeds.org
MEDICATION MANAGEMENT IMPROVEMENT SYSTEM: HomeMeds SM The HomeMeds SM system is a collaborative approach to identifying, assessing, and resolving medication problems in community-dwelling older adults.
Clinical pathway concept - a key to seamless care
SECTION 5: PATIENT SAFETY AND QUALITY ASSURANCE 1 Clinical pathway concept - a key to seamless care Audrey Janoly-Dumenil, Hôpital Edouard Herriot, CHU Lyon Marie-Camille Chaumais, Hôpital Antoine Béclère,
CROSS-CULTURAL EDUCATION PRIMER
CROSS-CULTURAL EDUCATION PRIMER Goal of Primer Background Key Components of Cross-Cultural Care References Developed by the Culturally Competent Care Education Committee at HMS, the following is a brief
Workshop on Patient Support and Market Research Programmes
Workshop on Patient Support and Market Research Programmes Spectrum of programmes falling under the terms of PSP and MRPs and the and the type of safety data collected Pharmaceutical Industry Associations
PHARMACEUTICAL MANAGEMENT PROCEDURES
PHARMACEUTICAL MANAGEMENT PROCEDURES THE FORMULARY The purpose of Coventry Health Care s formulary is to encourage use of the most cost-effective drugs. The formulary is necessary because the cost of prescription
Understanding Rheumatoid Arthritis
Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis What Is Rheumatoid Arthritis? 1,2 Rheumatoid arthritis (RA) is a chronic autoimmune disease. It causes joints to swell and can result
Medicare Appeals: Part D Drug Denials. December 16, 2014
Medicare Appeals: Part D Drug Denials December 16, 2014 2013 Appeals Statistics by Type 23,716 Part D Reconsideration Appeals* Appeals Type Percentage of Total Appeals Appeals Per Million Medicare Beneficiaries
Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain
Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Section I: Preamble The Michigan Boards of Medicine and Osteopathic Medicine & Surgery recognize that principles of quality
West Virginia University School of Pharmacy Educational Outcomes Professional Curriculum Approved by the Faculty: October 11, 2013
West Virginia University School of Pharmacy Educational Outcomes Professional Curriculum Approved by the Faculty: October 11, 2013 1 Preamble The School of Pharmacy s educational outcomes (EOs) are designed
British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Medication Adherence Services
British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Introduction Medication adherence can be generally defined as the extent to which a patient takes medication as prescribed by his
Patients' Satisfaction with Primary Health Care Services at Capital Health Region, Kuwait
Middle East Journal of Family Medicine, 25; Vol. 3 (3) Patients' Satisfaction with Primary Health Care Services at Capital Health Region, Kuwait Authors: Ibrahim S Al-Eisa (), Manal S Al-Mutar (2), Maged
Arthritis Research UK Epidemiology Unit
Arthritis Research UK Epidemiology Unit Qualitative research proposal to explore factors influencing acceptable risk thresholds used to recommend particular treatment options for rheumatoid arthritis.
Biologic Treatments for Rheumatoid Arthritis
Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been
Guidance on competencies for management of Cancer Pain in adults
Guidance on competencies for management of Cancer Pain in adults Endorsed by: Contents Introduction A: Core competencies for practitioners in Pain Medicine B: Competencies for practitioners in Pain Medicine
Arthritis Foundation Position Statement on Biosimilar Substitution
Arthritis Foundation Position Statement on Biosimilar Substitution The Affordable Care Act creates a regulatory pathway for the approval of a new generation of biologic medications called biosimilars.
Barriers to Effective Pain Management. Dr. Huda Abu-Saad Huijer Director Hariri School of Nursing
Barriers to Effective Pain Management Dr. Huda Abu-Saad Huijer Director Hariri School of Nursing Introduction Unrelieved pain is a major, yet avoidable, public health problem. Despite more than 30 years
S1. Which of the following age categories do you fall into? Please select one answer only. 18-44 years of age. 45-64 years of age. 65-74 years of age
Supplemental Materials Supplemental Methods Patient Survey We are presently conducting a market research study to help us better understand some of the challenges experienced by patients taking anticoagulants
GUIDELINES FOR USE OF PSYCHOTHERAPEUTIC MEDICATIONS IN OLDER ADULTS
GUIDELINES GUIDELINES FOR USE OF PSYCHOTHERAPEUTIC MEDICATIONS IN OLDER ADULTS Preamble The American Society of Consultant Pharmacists has developed these guidelines for use of psychotherapeutic medications
2015 PROVIDER TOOLKIT Understanding the Centers for Medicare and Medicaid (CMS) Stars Rating System
Understanding the Centers for Medicare and Medicaid (CMS) Stars Rating System 7990 IH 10 West, Suite 300 San Antonio, TX 78230 What is CMS Quality Star Ratings program? CMS evaluates health insurance plans
RMIP Prescription Plan FAQ's
RMIP Prescription Plan FAQ's A new U.S. Pharmacy Benefit Manager has been selected for January 1, 2015 - CVS/caremark. 1) Why is the RMIP changing to CVS/caremark? The Express Scripts contract ends on
Virtual Mentor American Medical Association Journal of Ethics March 2009, Volume 11, Number 3: 242-246.
Virtual Mentor American Medical Association Journal of Ethics March 2009, Volume 11, Number 3: 242-246. HEALTH LAW Difficult Patient-Physician Relationships and the Risk of Medical Malpractice Litigation
Administration of Emergency Medicine
doi:10.1016/j.jemermed.2005.07.008 The Journal of Emergency Medicine, Vol. 30, No. 4, pp. 455 460, 2006 Copyright 2006 Elsevier Inc. Printed in the USA. All rights reserved 0736-4679/06 $ see front matter
Guidelines for the Practice and Documentation of Comprehensive Medication Management in the Patient-Centered Medical Home
APPENDIX A: Guidelines Guidelines for the Practice and Documentation of Comprehensive Medication Management in the Patient-Centered Medical Home Based on Information Contained in the PCPCC Resource Guide:
Morgan Schultz 1, Stephanie Keeling 2, Steven Katz 2, Walter Maksymowych 2, Dean Eurich 3, Jill Hall 1 1
Morgan Schultz 1, Stephanie Keeling 2, Steven Katz 2, Walter Maksymowych 2, Dean Eurich 3, Jill Hall 1 1 Faculty of Pharmacy and Pharmaceutical Sciences, 2 Faciluty of Medicine and Dentistry, 3 School
Not All Clinical Trials Are Created Equal Understanding the Different Phases
Not All Clinical Trials Are Created Equal Understanding the Different Phases This chapter will help you understand the differences between the various clinical trial phases and how these differences impact
Rheumatoid Arthritis: Symptoms, Causes, and Treatments of Rheumatoid Foot and Ankle
Rheumatoid arthritis is the most common form of inflammatory arthritis, affecting about two to three million Americans. Rheumatoid arthritis is a symmetric disease, meaning that it will usually involve
Drug Utilization and Evaluation of Cephalosporin s At Tertiary Care Teaching Hospital, Bangalore
Research Article Drug Utilization and Evaluation of Cephalosporin s At Tertiary Care Teaching Hospital, Bangalore HS. Shekar 1*, HR. Chandrashekhar 2, M. Govindaraju 3, P. Venugopalreddy 1, Chikkalingiah
Time to Act Urgent Care and A&E: the patient perspective
Time to Act Urgent Care and A&E: the patient perspective May 2015 Executive Summary The NHS aims to put patients at the centre of everything that it does. Indeed, the NHS Constitution provides rights to
Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain
JENNIFER M. GRANHOLM GOVERNOR STATE OF MICHIGAN DEPARTMENT OF COMMUNITY HEALTH LANSING JANET OLSZEWSKI DIRECTOR Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment
Quantifying Medication Adherence: Practical Challenges and an Approach to Linking Alternative Measures
Quantifying Medication Adherence: Practical Challenges and an Approach to Linking Alternative Measures Christine Poulos, PhD, RTI Health Solutions Jay P. Bae, PhD, Eli Lilly and Company Sean D. Candrilli,
Thrifty White Pharmacy 9/5/2014. Specialty Pharmacy. Specialty Pharmacy: The Opportunities and the Challenges
Specialty Pharmacy: The Opportunities and the Challenges MPhA Annual Conference September 12, 2014 Justin Heiser, PharmD Senior Vice President, Pharmacy Operations Specialty Pharmacy High cost and/or high
8/14/2012 California Dual Demonstration DRAFT Quality Metrics
Stakeholder feedback is requested on the following: 1) metrics 69 through 94; and 2) withhold measures for years 1, 2, and 3. Steward/ 1 Antidepressant medication management Percentage of members 18 years
PRACTICE BRIEF. Preventing Medication Errors in Home Care. Home Care Patients Are Vulnerable to Medication Errors
PRACTICE BRIEF FALL 2002 Preventing Medication Errors in Home Care This practice brief highlights the results of two home health care studies on medication errors. The first study determined how often
Attitudes and Beliefs About the Use of Over-the-Counter Medicines: A Dose of Reality
Attitudes and Beliefs About the Use of Over-the-Counter Medicines: A Dose of Reality A National Survey of Consumers and Health Professionals Prepared for: National Council on Patient Information and Education
Medical College of Georgia Augusta, Georgia School of Medicine Competency based Objectives
Medical College of Georgia Augusta, Georgia School of Medicine Competency based Objectives Medical Knowledge Goal Statement: Medical students are expected to master a foundation of clinical knowledge with
To provide standardized Supervised Exercise Programs across the province.
TITLE ALBERTA HEALTHY LIVING PROGRAM SUPERVISED EXERCISE PROGRAM DOCUMENT # HCS-67-01 APPROVAL LEVEL Executive Director Primary Health Care SPONSOR Senior Consultant Central Zone, Primary Health Care CATEGORY
CLINICAL PRACTICE GUIDELINES Treatment of Schizophrenia
CLINICAL PRACTICE GUIDELINES Treatment of Schizophrenia V. Service Delivery Service Delivery and the Treatment System General Principles 1. All patients should have access to a comprehensive continuum
Performance Standards
Performance Standards Co-Occurring Disorder Competency Performance Standards are intended to provide a foundation and serve as a tool to promote continuous quality improvement and progression toward best
NH Medicaid Managed Care Supplemental Issue
Empowering and informing families and professionals caring for children with special health care needs and disabilities from birth to adulthood. NH Medicaid Managed Care Supplemental Issue In 2011 the
The Use of Electronic signatures for Prescribing Chemotherapy and data entries on the Aria MedOncology system V3.0
The Use of Electronic signatures for Prescribing Chemotherapy and data entries on the Aria MedOncology system V3.0 January 2013 Table of Contents 1. Introduction... 3 2. Purpose of this Policy... 3 3.
ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS
ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS 610-X-5-.01 610-X-5-.02 610-X-5-.03 610-X-5-.04 610-X-5-.05 610-X-5-.06 610-X-5-.07
ABOUT RHEUMATOID ARTHRITIS
MEDIA BACKGROUNDER ABOUT RHEUMATOID ARTHRITIS Rheumatoid arthritis (RA) is a type of arthritis (chronic inflammatory polyarthritis) that typically affects hands and feet, although any joint in the body
